The French Langerhans’ Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993 The French Langerhans’ Cell Histiocytosis study group. Arch Dis Child. 1996;75(1):17–24.

Article  Google Scholar 

Roy C, Silverman A, Alaguille D. Diseases of the liver: prolonged obstructive jaundice including calculous and non calculous gallbladder conditions pediatric clinical gastroenterology St Louis. Missouri. 1995;11(5):636–83.

Google Scholar 

Zandi P, Panis Y, Debray D, Bernard O, Houssin D. Pediatric liver transplantation for Langerhans’ cell histiocytosis. Hepatology. 1995;21(1):129–33.

Article  PubMed  Google Scholar 

Kudo K, Toki T, Kanezaki R, Tanaka T, Kamio T, Sato T, et al. BRAFV600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis. Haematologica. 2022;107(7):1719–25.

Article  PubMed  PubMed Central  Google Scholar 

Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H, Sakashita K, et al. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell histiocytosis study group-02 protocol study. Int J Hematol. 2016;104(1):99–109.

Article  PubMed  Google Scholar 

https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm

Braier J, Ciocca M, Latella A, de Davila MG, Drajer M, Imventarza O. Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis. Med Pediatr Oncol. 2002;38(3):178–82.

Article  PubMed  Google Scholar 

Ziogas IA, Kakos CD, Wu WK, Montenovo MI, Matsuoka LK, Zarnegar-Lumley S, et al. Liver transplantation for langerhans cell histiocytosis: a US population-based analysis and systematic review of the literature. Liver Transpl. 2021;27(8):1181–90. https://doi.org/10.1002/lt.25995.

Article  PubMed  Google Scholar 

Newell KA, Alonso EM, Kelly SM, Rubin CM, Thistlethwaite JR Jr, Whitington PF. Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children. J Pediatr. 1997;131:98–104.

Article  PubMed  Google Scholar 

Hadzic N, Pritchard J, Webb D, Portmann B, Heaton ND, Rela M, et al. Recurrence of Langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation. 2000;70(5):815–9.

Article  PubMed  Google Scholar 

Tfifha M, Kamoun T, Mama N, Mestiri S, Hassayoun S, Zouari N, et al. Childhood sclerosing cholangitis associations in a Tunisian tertiary care hospital: a many-faced disease. Turk J Pediatr. 2019;61:905–14.

Article  PubMed  Google Scholar 

Melendez HV, Dhawan A, Mieli-Vergani G, Rela M, Heaton ND, Pritchard J, et al. Liver transplantation for Langerhans’ cell histiocytosis-a case report and literature review. Transplantation. 1996;62(8):1167–71. Accessed 5 April 2022.

Article  PubMed  Google Scholar 

Murakami M, Onishi S, Ohya Y, Kawabata S, Isono K, Sugawara Y, et al. Langerhans cell histiocytosis confined to extrahepatic bile duct causing sclerosing cholangitis in child: a case report. Surg Case Rep. 2020;6(1):137. https://doi.org/10.1186/s40792-020-00899-6.

Article  PubMed  PubMed Central  Google Scholar 

Honda R, Ohno Y, Iwasaki T, Okudaira S, Okada M, Kamitamari A, et al. Langerhans’ cell histiocytosis after living donor liver transplantation: report of a case. Liver Transpl. 2005;11(11):1435–8.

Article  PubMed  Google Scholar 

Al Salloom AA, Almalki ST, Almana H, Burdelski M. Diabetes insipidus and sclerosing cholangitis in a child may be a clue to the diagnosis of Langerhans’ cell histiocytosis: a case report. Int J Health Sci (Qassim). 2013;7(2):248–51.

PubMed  Google Scholar 

Rajwal SR, Stringer MD, Davison SM, Gerrard M, Glaser A, Tanner MS, et al. Use of basiliximab in pediatric liver transplantation for Langerhans cell histiocytosis. Pediatr Transplant. 2003;7(3):247–51.

Article  PubMed  Google Scholar 

Badalian-Very G, Vergilio JA, Degar BA, MacConail LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919–23.

Article  PubMed  PubMed Central  Google Scholar 

Kobayashi M, Tojo A. Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment. Cancer Sci. 2018;109:3707–13.

Article  PubMed  PubMed Central  Google Scholar 

Héritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, et al. BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol. 2016;34(25):3023–30.

Article  PubMed  PubMed Central  Google Scholar 

Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, et al. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017;130(2):167–75.

Article  PubMed  PubMed Central  Google Scholar 

Cui L, Zhang L, Ma HH, Wang CJ, Wang D, Lian HY, et al. Circulating cell-free BRAFV600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis. Haematologica. 2020;105(9):e444-447.

Article  PubMed  PubMed Central  Google Scholar 

Schwentner R, Kolenová A, Jug G, Schnöller T, Ahlmann M, Meister B, et al. Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis. Pediatr Res. 2019;85(6):856–64.

Article  PubMed  Google Scholar